{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:46:07Z","timestamp":1787013967095,"version":"build-2736575974"},"reference-count":51,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Purpose<\/jats:title>\n                    <jats:p>Therapeutic hypothermia (TH) has become the standard care to reduce morbidity and mortality in neonates affected by moderate\u2010to\u2010severe hypoxic\u2013ischaemic encephalopathy (HIE). Despite the use of TH for HIE, the incidence of mortality and disabilities remains high.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Experimental Approach<\/jats:title>\n                    <jats:p>Nerve growth factor (NGF) is a potent neurotrophin, but clinical use is limited by its pain eliciting effects. CHF6467 is a recombinant modified form of human NGF devoid of algogenic activity (painless NGF).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Results<\/jats:title>\n                    <jats:p>\n                      In rodent hippocampal slices exposed to oxygen and glucose deprivation, CHF6467 protected neurons from death and reverted neurotransmission impairment when combined with hypothermia. In a model of rat neonatal HIE, intranasal CHF6467 (20\u2009\u03bcg\u2009kg\n                      <jats:sup>\u22121<\/jats:sup>\n                      ) significantly reduced brain infarct volume versus vehicle when delivered 10\u00a0min or 3\u00a0h after the insult. CHF6467 (20 and 40\u2009\u03bcg\u2009kg\n                      <jats:sup>\u22121<\/jats:sup>\n                      , i.n.), significantly decreased brain infarct volume to a similar extent to TH and when combined, showed a synergistic neuroprotective effect. CHF6467 (20\u2009\u03bcg\u2009kg\n                      <jats:sup>\u22121<\/jats:sup>\n                      , i.n.) per se and in combination with hypothermia reversed locomotor coordination impairment (Rotarod test) and memory deficits (Y\u2010maze and novel object recognition test) in the neonatal HIE rat model. Intranasal administration of CHF6467 resulted in meaningful concentrations in the brain, blunted HIE\u2010induced mRNA elevation of brain neuroinflammatory markers and, when combined to TH, significantly counteracted the increase in plasma levels of neurofilament light chain, a peripheral marker of neuroaxonal damage.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion and Implications<\/jats:title>\n                    <jats:p>CHF6467 administered intranasally is a promising therapy, in combination with TH, for the treatment of HIE.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/bph.17353","type":"journal-article","created":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T22:59:06Z","timestamp":1728428346000},"page":"510-529","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Beneficial effects of CHF6467, a modified human nerve growth factor, in experimental neonatal hypoxic\u2013ischaemic encephalopathy"],"prefix":"10.1111","volume":"182","author":[{"given":"Elisa","family":"Landucci","sequence":"first","affiliation":[{"name":"Department of Health Sciences, Section of Clinical Pharmacology and Oncology University of Florence  Florence Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalila","family":"Mango","sequence":"additional","affiliation":[{"name":"Laboratory Pharmacology of Synaptic Plasticity European Brain Research Institute  Rome Italy"},{"name":"School of Pharmacy University of Rome \u201cTor Vergata\u201d  Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Carloni","sequence":"additional","affiliation":[{"name":"Department of Biomolecular Sciences University of Urbino Carlo Bo  Urbino Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costanza","family":"Mazzantini","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Section of Clinical Pharmacology and Oncology University of Florence  Florence Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico E.","family":"Pellegrini\u2010Giampietro","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Section of Clinical Pharmacology and Oncology University of Florence  Florence Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira","family":"Saidi","sequence":"additional","affiliation":[{"name":"Laboratory Pharmacology of Synaptic Plasticity European Brain Research Institute  Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Balduini","sequence":"additional","affiliation":[{"name":"Department of Biomolecular Sciences University of Urbino Carlo Bo  Urbino Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Schiavi","sequence":"additional","affiliation":[{"name":"Corporate Preclinical R&amp;D Chiesi Farmaceutici  Parma Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Tigli","sequence":"additional","affiliation":[{"name":"Corporate Preclinical R&amp;D Chiesi Farmaceutici  Parma Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Pioselli","sequence":"additional","affiliation":[{"name":"Corporate Preclinical R&amp;D Chiesi Farmaceutici  Parma Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno P.","family":"Imbimbo","sequence":"additional","affiliation":[{"name":"Corporate Preclinical R&amp;D Chiesi Farmaceutici  Parma Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3505-4159","authenticated-orcid":false,"given":"Fabrizio","family":"Facchinetti","sequence":"additional","affiliation":[{"name":"Corporate Preclinical R&amp;D Chiesi Farmaceutici  Parma Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,10,8]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.16180"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.51.3.695"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1177\/039463201102400320"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/1742-9994-12-S1-S17"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017321"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww271"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.27.6.1060"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2024.e00341"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/02699052.2017.1376760"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00381-020-04590-x"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1177\/00236772221097472"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2009.11.146"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13062-023-00379-5"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15868"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000198867.31134.ac"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.12723"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2019.02.023"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13062-023-00418-1"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-536-7_29"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2015.13"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23084180"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.15-02-01567.1995"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410390117"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1159\/000017069"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2018.01.023"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22189773"},{"key":"e_1_2_12_28_1","first-page":"937","article-title":"Experimental models for testing the efficacy of pharmacological treatments for neonatal hypoxic\u2010ischemic encephalopathy","volume":"10","author":"Landucci E.","year":"2022","journal-title":"Biomedicine"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2010.11.021"},{"key":"e_1_2_12_30_1","first-page":"3481","article-title":"Intranasal administration of nerve growth factor promotes angiogenesis via activation of PI3K\/Akt signaling following cerebral infarction in rats","volume":"10","author":"Li X.","year":"2018","journal-title":"American Journal of Translational Research"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15178"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2022.969058"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-74046-7_1"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2012.11.028"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136425"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00555"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.754502"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.354513"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.16056"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2017.00078"},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18051028"},{"key":"e_1_2_12_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/d41573-023-00083-z"},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2016.11.027"},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.1042\/BST20130247"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjos-2020-100115"},{"key":"e_1_2_12_46_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.00486"},{"key":"e_1_2_12_47_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.112.674481"},{"key":"e_1_2_12_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2017.01.035"},{"key":"e_1_2_12_49_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0688-19.2019"},{"key":"e_1_2_12_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2011.12.059"},{"key":"e_1_2_12_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/0471142301.ns0831s69"},{"key":"e_1_2_12_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-00528-4"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bph.17353","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T03:20:49Z","timestamp":1737602449000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bph.17353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,8]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1111\/bph.17353"],"URL":"https:\/\/doi.org\/10.1111\/bph.17353","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,8]]},"assertion":[{"value":"2024-03-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}